Candesartan 16 mg (Candesartan Cilexetil)

Adult dose

For essential hypertension, an initial and maintenance dose of 8 to 16 mg of Candesartan Cilexetil is recommended, taken orally once daily. If blood pressure is not sufficiently controlled after four weeks of treatment at 16 mg once daily, the dose may be increased up to a maximum of 32 mg once daily. For heart failure, an initial dose of 4 mg once daily is recommended, with an increase of the dose by twofold at intervals of at least two weeks, up to a maximum of 32 mg once daily.

Child dose

Safety and efficacy for adolescents and children under 18 years have not been established.

This medication poses a serious risk of harm to the fetus or newborn during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used by individuals allergic to this medication or its components, pregnant or breastfeeding women, patients with severe liver dysfunction, or patients with hereditary angioedema. Caution is advised for the elderly, patients with hyperkalemia, patients with mild liver function impairment, and patients with heart valve disease or obstructive cardiomyopathy. Mild side effects such as dizziness, back pain, and respiratory infections may occur during this medication's usage, and in rare cases, severe allergic reactions, renal function impairment, or hypotension may occur, necessitating immediate consultation with healthcare providers if symptoms arise. Especially, patients with heart failure or compromised renal function should regularly monitor potassium levels and renal function for any abnormalities. Caution is required during driving or operating machinery due to potential dizziness or fatigue resulting from blood pressure reduction. Combining this medication with other antihypertensives or potassium-sparing diuretics may increase the risk of side effects, so consultation with a healthcare provider is necessary before use. Women who are pregnant or planning to become pregnant should not use this medication, and it is advisable to avoid use while breastfeeding. Safety and efficacy for children and adolescents have not been established, so usage is not recommended in these groups. In the case of overdose, symptoms may include hypotension, dizziness, and tachycardia; appropriate treatment should be sought immediately at a medical institution. This medication should be stored out of reach of children and should not be transferred to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, peeling skin, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough + fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• back pain
• respiratory infections
• fatigue
• peripheral edema
• chest pain
• headache
• bronchitis
• cough
• sinusitis

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius. Storing it this way ensures the medication's efficacy is safely maintained.

Appearance

Round tablets with a convex face, light yellowish-pink in color.

Package unit

30 tablets/bottle, 100 tablets/bottle, 30 tablets (10 tablets/PTP*3, for export)